Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 23441865)

1.

3D-QSAR and molecular docking for the discovery of ketolide derivatives.

Ruan ZX, Huangfu DS, Xu XJ, Sun PH, Chen WM.

Expert Opin Drug Discov. 2013 Apr;8(4):427-44. doi: 10.1517/17460441.2013.774369. Epub 2013 Feb 26. Review.

PMID:
23441865
2.

Synthesis and biological activity of new 5-O-sugar modified ketolide and 2-fluoro-ketolide antibiotics.

Liang CH, Yao S, Chiu YH, Leung PY, Robert N, Seddon J, Sears P, Hwang CK, Ichikawa Y, Romero A.

Bioorg Med Chem Lett. 2005 Mar 1;15(5):1307-10.

PMID:
15713376
3.
4.

9-Oxime-3-ketolides: modification at the C-11,12-diol moiety and antibacterial activities against key respiratory pathogens.

Nomura T, Yasukata T, Narukawa Y, Uotani K.

Bioorg Med Chem. 2005 Nov 1;13(21):6054-63.

PMID:
15994088
5.

Synthesis and antibacterial evaluation of a novel series of 10-hydroxyl ketolide derivatives.

Jiang JW, Sun Y, Nie Y, Zhi HJ, Zhang XJ, Li X, Sun HP, You QD.

Bioorg Med Chem Lett. 2013 Jun 1;23(11):3452-7. doi: 10.1016/j.bmcl.2013.03.057. Epub 2013 Apr 3.

PMID:
23591116
6.

Novel tethers in ketolide antibiotics.

Kaneko T, Romero K, Li B, Buzon R.

Bioorg Med Chem Lett. 2007 Sep 15;17(18):5049-53. Epub 2007 Jul 13.

PMID:
17659873
7.

Recent developments on ketolides and macrolides.

Wu YJ, Su WG.

Curr Med Chem. 2001 Dec;8(14):1727-58. Review.

PMID:
11562291
8.

The emerging new generation of antibiotic: ketolides.

Zhong P, Shortridge V.

Curr Drug Targets Infect Disord. 2001 Aug;1(2):125-31. Review.

PMID:
12455409
9.

Distinct mode of interaction of a novel ketolide antibiotic that displays enhanced antimicrobial activity.

Kouvela EC, Kalpaxis DL, Wilson DN, Dinos GP.

Antimicrob Agents Chemother. 2009 Apr;53(4):1411-9. doi: 10.1128/AAC.01425-08. Epub 2009 Jan 21.

11.
12.

Synthesis and antibacterial activity of 6-O-(heteroaryl-isoxazolyl)propynyl 2-fluoro ketolides.

Sugimoto T, Shimazaki Y, Manaka A, Tanikawa T, Suzuki K, Nanaumi K, Kaneda Y, Yamasaki Y, Sugiyama H.

Bioorg Med Chem Lett. 2012 Sep 1;22(17):5739-43. doi: 10.1016/j.bmcl.2012.06.092. Epub 2012 Jul 6.

PMID:
22858102
13.

C-9 Alkenylidine bridged macrolides: WO2008061189. Enanta Pharmaceuticals, Inc.

Poce G, Cesare Porretta G, Biava M.

Expert Opin Ther Pat. 2009 Jun;19(6):901-6. doi: 10.1517/13543770902762901.

PMID:
19473109
14.

Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.

Agouridas C, Denis A, Auger JM, Benedetti Y, Bonnefoy A, Bretin F, Chantot JF, Dussarat A, Fromentin C, D'Ambrières SG, Lachaud S, Laurin P, Le Martret O, Loyau V, Tessot N.

J Med Chem. 1998 Oct 8;41(21):4080-100.

PMID:
9767644
15.

Synthesis and antibacterial activity of novel C12 ethyl ketolides.

Burger MT, Hiebert C, Seid M, Chu DT, Barker L, Langhorne M, Shawar R, Kidney J, Desai MC, Plattner JJ.

Bioorg Med Chem. 2006 Aug 15;14(16):5592-604. Epub 2006 May 11.

PMID:
16697203
16.

Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections.

Hammerschlag MR, Sharma R.

Expert Opin Investig Drugs. 2008 Mar;17(3):387-400. doi: 10.1517/13543784.17.3.387 . Review.

PMID:
18321237
17.

QSAR methods for the discovery of new inflammatory bowel disease drugs.

García-Domenech R, Gálvez-Llompart M, Zanni R, Recio MC, Gálvez J.

Expert Opin Drug Discov. 2013 Aug;8(8):933-49. doi: 10.1517/17460441.2013.800043. Epub 2013 May 14. Review.

PMID:
23668227
18.

Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.

AbdulHameed MD, Hamza A, Liu J, Zhan CG.

J Chem Inf Model. 2008 Sep;48(9):1760-72. doi: 10.1021/ci800147v. Epub 2008 Aug 22.

PMID:
18717540
19.

Synthesis and antibacterial activity of novel modified 5-O-desosamine ketolides.

Chen X, Xu P, Xu Y, Liu L, Liu Y, Zhu D, Lei P.

Bioorg Med Chem Lett. 2012 Dec 15;22(24):7402-5. doi: 10.1016/j.bmcl.2012.10.064. Epub 2012 Oct 23.

PMID:
23122862
20.

3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.

Prado-Prado F, García-Mera X, Escobar M, Alonso N, Caamaño O, Yañez M, González-Díaz H.

Curr Top Med Chem. 2012;12(16):1843-65.

PMID:
23030618
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk